Search

Your search keyword '"Raman, Jay"' showing total 2,076 results

Search Constraints

Start Over You searched for: Author "Raman, Jay" Remove constraint Author: "Raman, Jay"
2,076 results on '"Raman, Jay"'

Search Results

1. MP17-06 IMPACT OF SUBSEQUENT FELLOWSHIP ON CHIEF RESIDENT CASE LOG VOLUMES

2. MP17-04 TRENDS IN CHIEF RESIDENT CASE LOGS VERSUS SUBSEQUENT CASE LOG DATA IN CLINICAL PRACTICE

3. Practice Readiness? Trends in Chief Resident Year Training Experience Across 13 Residency Programs

9. Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.

10. Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology Residents

16. Management of Residual or Recurrent Disease Following Thermal Ablation of Renal Cortical Tumors.

17. Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative

18. Reply by Authors

19. PD20-07 ONCOLOGIC OUTCOMES IN PATIENTS WITH VARIANT HISTOLOGIES OF UPPER TRACT UROTHELIAL CANCER: RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT

21. PD23-05 UNDERSTANDING THE UNDERUTILIZATION OF GENETIC EVALUATION IN PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA

22. PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE

24. MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)

25. MP71-17 10-YEAR TRENDS IN PERIOPERATIVE OUTCOMES IN BLADDER CANCER PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH ILEAL CONDUIT URINARY DIVERSION

26. PD18-06 VALIDATION OF THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) MODEL USING AN INDEPENDENT CONTEMPORARY MULTI-CENTER COHORT

27. MP38-02 PATTERNS OF NON-UROTHELIAL RECURRENCE AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (UCAN COLLABORATION)

28. PD20-08 RESPONSE TO NEOADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA—AN UPPER TRACT COLLABORATIVE NETWORK (UCAN) STUDY

29. Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study

33. Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation

34. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation

36. Appropriateness of Imaging for Low-Risk Prostate Cancer—Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC).

37. Prior Negative Biopsy, PSA Density, and Anatomic Location Impact Cancer Detection Rate of MRI-Targeted PI-RADS Index Lesions.

42. DEFINING THE IMPACT OF PERSONAL AND FAMILY HISTORY OF LYNCH-SYNDROME ASSOCIATED CANCERS ON CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA

43. DISPARITIES IN UTILIZATION OF GENETIC EVALUATION IN PATIENTS WITH KIDNEY CANCER WHO MEET GUIDELINES FOR GENETIC REFERRAL

44. ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER

45. NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT

46. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy

Catalog

Books, media, physical & digital resources